TRADING UPDATES: Cordel hails AI-enhanced partnership with VRSD
20th Jan 2025 14:27
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and last week and not separately reported by Alliance News: Read More
OptiBiotix Health PLC - York-based life sciences firm - Says Finance Director Graham Myers will step down on November 30 and be replaced by David Blain, who will join as acting Finance Director on November 1. David Blain is currently financial director at Iksuda Therapeutics Ltd. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by Alliance News: Read More
ProBiotix Health PLC - Wakefield, England-based life sciences business developing probiotics to tackle cardiovascular disease and other lifestyle conditions - OptiBiotix Health PLC, a York-based life sciences peer and major shareholder of ProBiotix, says it will vote in favour of the resolutions put forward by fellow shareholder Seneca Partners. ProBiotix on Wednesday confirmed it had received a requisition notice from a nominee of 5.5% shareholder Seneca, calling for a general meeting to vote on proposals to remove two ProBiotix directors, including Chief Executive Officer Steen Andersen. ProBiotix said all of its directors, other than Stephen O'Hara, who also is chief executive of OptiBiotix, support keeping both directors in place. Read More
(Alliance News) - ProBiotix Health PLC on Friday defended the validity of its recent GBP1.2 million fundraise, despite protestations from shareholder OptiBiotix Health PLC. Read More
(Alliance News) - OptiBiotix Health PLC on Tuesday said it was confident in its outlook as it was gaining commercial traction with large partners. Read More
OptiBiotix Health PLC - York, England-based life sciences company - On Thursday, notes that study outcomes at Roehampton University in London suggested the company's SlimBiome "had a major impact on insulin response combined with significantly lower feelings of hunger, a lower desire to eat, and significantly higher levels of fullness within 15 minutes, for over two hours after consumption". Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - OptiBiotix Health PLC on Monday said it has raised GBP1.4 million through a placing and subscription of shares. Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
(Alliance News) - OptiBiotix Health PLC shares rose on Tuesday as the firm celebrated a "gradual return to strong sales growth". Read More
OptiBiotix Health PLC - York, England-based life sciences company - Hails "significant progress" in SweetBiotix commercial scale production. Says it is currently in discussions with commercial partners to launch SweetBiotix products. SweetBiotix is a low calorie alternative to sugar. Chief Executive Officer Stephen O'Hara says: "Consumer concerns over sugar and the safety of several sugar substitutes have materialised into companies reformulating existing and/or launching new products containing natural, safe, and healthy alternatives. The company believes its sweet, high fibre, low calorie, prebiotic fibre SweetBiotix products are ideally positioned to launch at a time when many companies are actively looking for a natural alternative to meet this need." Read More
(Alliance News) - OptiBiotix Health PLC on Monday announced the launch of LeanBiome in sports nutrition brand, MuscleTech. Read More
OptiBiotix Health PLC - York, England-based life sciences company - Appoints Graham Myers as finance director, effective as of December 1, 2023. Says that Myers' appointment to this part-time role will see him work closely with the OptiBiotix team to support its focus on "driving each business unit and the group to profitability". Myers is currently chair of Croda Pension Trustees Ltd, the sole trustee of Croda International PLC's GBP800 million UK pension scheme. Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
(Alliance News) - OptiBiotix Health PLC on Wednesday said sales from existing partners have improved in recent months, and that its move to focus on US and Asian markets is progressing well. Read More
(Alliance News) - OptiBiotix Health PLC on Monday said it agreed a licence deal with Tata Chemicals Ltd to incorporate Tata's short-chain fructo-oligosaccharide Fossence into OptiBiotix's SlimBiome and LeanBiome products for the Indian market. Read More